He Ye entered into share transfer agreement to acquire 51% stake in Yingkou Sanhua Pharmaceutical Co., Ltd. from Hunan Fangsheng Pharmaceutical Co., Ltd. (SHSE:603998) for CNY 24 million on May 22, 2021. Within 5 working days after the effective date of the agreement, the buyer will pay 20% and 20% will be paid at completion. Within 1 month after the completion of the delivery, the buyer will pay CNY4.90 million. Within 6 months after the completion of the delivery, the buyer will pay CNY9.50 million. In related transaction, Changsha Fanghua Pharmaceutical Consulting Partnership Enterprise will transfer 10% stake in Sanhua Pharmaceutical to He Ye for CNY 1.3 million. As of March 31, 2021, Sanhua Pharmaceutical had total asset and net asset as CNY 23 million and CNY 13.8 million. For year ended December 31, 2020, It had revenue and net loss as CNY 3.6 million and CNY 1.7 million. On May 22, 2021, the 5th session of the company’s 5th directorate for 2021 approved the
Share
© S&P Capital IQ - 2021